Bayer Schering Pharma in research pact with China's largest military hospital
20 Jul 2010
Bayer Schering Pharma AG, Germany, has reached a research collaboration agreement with the largest military hospital in China, The People's Liberation Army General Hospital 301, located in Beijing, to set up women's healthcare facilities.
Under the terms of the agreement, 301 Hospital will receive research funding and its scientists will be able to work at Bayer Schering Pharma's research facilities in Berlin, Germany. Bayer Schering Pharma scientists from the recently established Bayer Schering Pharma Global Drug Discovery's China innovation centre in Beijing will participate in and coordinate the research projects.
The joint research programs will initially be focused on, but not limited to, gynecological diseases. Their first project will focus on the establishment and analysis of disease models and disease understanding.
''Working together with the experts from The People's Liberation Army General Hospital will help us to bring new therapies faster to patients suffering from gynecological diseases, like endometriosis and uterine fibroids," said Prof. Andreas Busch, member of the board of management at Bayer Schering Pharma and head of global drug discovery.
301 Hospital is one of the biggest general hospitals in China and has a reputation for gynecology and obstetrics research and treatment of patients suffering from related diseases.
Prof. Guoquan Ren, head of medical management division, said,''Endometriosis and uterine fibroids are severe diseases that significantly compromise the health and quality of life of women. Joining forces will allow us to take advantage of each other's strengths which will for sure drive the research and innovation in these fields.''
Founded in 1953, 301 Hospital, with a complete range of clinical disciplines, provides one of the most comprehensive hospital facilities among military hospitals throughout China. It employs over 3,600 professionals across 12 medical specialty centres, 14 medical research centres and eight major laboratories, engaging in various key medical disciplines such as otolaryngology, orthopedics, gynecology, and gerontology, among others.
